Indian Pharmaceutical Market Over view & Snap Shot April'2021
IPM performance for the Indian Pharma Industry seen a robust growth of 51.5% for the month of April 21. Major three reasons is there for this which we have addressed below:-
3 major reasons for this tremendous growth:
- Correction made by pharma companies for their dip that was happen in Apr'20.
- Second wave of Covid has further boosted the sales of drugs related to Covid treatment & many others essential drugs. Therefore we can see that Anti-infectives market showing a growth of 134% and Nutritionals market with a growth of 76%. Those companies involve in Covid treatment therapy segments have gained substantially growth through their bumper sales for the month.
- Now Pharma industry are well prepared compare to last year of same month for production and distribution exigencies that are expected during lockdown.
Below is the List & Rank of Top 50 Pharma Corporates in India (IPM, Apr'21)
Substantial changes has happened for ranking of companies for this month due to above discussed reasons.